SYDNEY, Oct. 20, 2026 (GLOBE NEWSWIRE) — Brazilian Rare Earths Limited (ASX: BRE / OTCQX: BRELY) (‘BRE’) is pleased to report progress during the quarter ended September 30, 2026. Highlights during and subsequent to the end of the quarter include:

MAIDEN ULTRA-HIGH GRADE MINERAL RESOURCE

  • World-leading rare earths grade: Monte Alto’s Mineral Resource grades 11.3% TREO, more than twice the reported grades of the two established large-scale Western rare earth producers.
  • Major new source of heavy rare earths plus strategic co-products: Strong dysprosium, terbium, gadolinium and yttrium enrichment, alongside potential uranium, scandium, niobium and tantalum co-products.

INTEGRATED MONTE ALTO + CAMAÇARI SCOPING STUDY

  • Exceptional economics: After-tax NPV₈ of US$6.0 billion, IRR of 90%, 1.1-year payback and average annual operating free cash flow of US$1.2 billion.1
  • First-quartile project: Ultra-high grades, simple ore sorting, high yields, established infrastructure and low-temperature processing underpin costs of ~US$21/kg NdPr equivalent.

SUCCESSFUL DRILLING POSITIONS MONTE ALTO FOR RESOURCE GROWTH

  • Ultra-high grade extensions: ~10,000 m of drilling completed after the 22 February 2026 Scoping Study cut-off expanded mineralisation south and east/down dip and established a priority growth corridor to the north.
  • Q4 2026 resource upgrade: Post-cut-off results could, subject to conversion into Mineral Resources and further studies, support mine life extension and/or increased annual production.

HIGH-GRADE SULISTA SOUTH DISCOVERY AND EXTENSIONS AT SULISTA EAST

  • New discovery and extensions: High-grade mineralisation intersected over ~500 m of strike at Sulista South, while step-out drilling extended Sulista East by 430 m.
  • Larger, higher-confidence resource targeted: Current step-out and infill drilling campaigns support potential resource growth and Inferred-to-Indicated conversion; updated mineral resource to follow their completion.

PRODUCED FIRST CONCENTRATE; SECURED STAGE II HYDROMET CO-FUNDING

  • First concentrate: Stage I commissioning at Camaçari advances bulk metallurgical testwork for the PFS.
  • Hydromet piloting: Stage II is 59% partner-funded, with commissioning planned for Q2 2027.

STRONG BALANCE SHEET TO FUND GROWTH

  • A$122 million cash and no borrowings at 30 September 2026.

A link to the complete announcement can be found: here

Contacts

Bernardo Da Veiga
Managing Director and CEO

investors@brazilianrareearths.com
www.brazilianrareearths.com

__________________________________
1 Argus EU/US price case. Refer to the Scoping Study cautionary statement in this report and BRE’s ASX announcement dated 18 August 2026.

Former CoBank CEO and Former CFO of Annie’s, KIND and BARK Join as Independent Directors

OCEANSIDE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) — Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,” “Suja” or the “Company”), a leading better-for-you beverage company and maker of Suja Organic, Vive Organic and Slice Soda, today announced the appointments of Robert B. Engel and Zahir Ibrahim as independent members of its Board of Directors (the “Board”), effective October 16, 2026. Engel will serve on the Board’s Audit Committee. With these appointments, Suja Life’s Board comprises nine directors, seven of whom are independent.

The appointments add deep financial, accounting and capital markets expertise to the Board as Suja Life continues to build its portfolio of better-for-you beverage brands. Engel, the former President and CEO of CoBank, brings more than 45 years of experience across banking, public accounting and public company board leadership. Ibrahim brings nearly 30 years of financial leadership at public and private consumer companies, including as Chief Financial Officer of Annie’s, KIND and BARK.

“We are pleased to welcome Bob Engel and Zahir Ibrahim to Suja Life’s Board of Directors,” said Bob DeBorde, Chairman of Suja Life. “Bob Engel brings extensive financial and risk oversight experience as well as deep knowledge of food and agribusiness as a former bank CEO, CPA and public company director. Zahir has served as CFO of leading natural and healthy consumer brands, including Annie’s and KIND, through periods of significant growth. Their perspectives will strengthen our Board as we execute our growth strategy and create long-term value for our shareholders.”

About Robert B. Engel

Engel spent 17 years at CoBank, ACB, first as President and Chief Operating Officer and then as President and Chief Executive Officer, leading the bank’s domestic and global businesses and its merger with U.S. AgBank. Before CoBank, he spent 14 years at HSBC Bank USA in roles of increasing responsibility, ultimately serving as Chief Banking Officer. He began his career in public accounting at Deloitte & Touche and KPMG, rising to Senior Audit Manager, and is a Certified Public Accountant.

Since 2017, Engel has served as Chief Executive Officer and Managing Director of BLT Advisory Services, LLC, an advisory firm he founded that guides companies on business transformation, mergers and acquisitions, governance and leadership development. He is also an independent director of Allient, Inc. (NASDAQ: ALNT), where he serves on the Audit Committee, and Chairman of the Board of Alaska Power & Telephone. He previously served as an independent director of Heartland Financial USA, Inc., then listed on NASDAQ, where he chaired the Risk Committee. Engel is a recipient of the Ellis Island Medal of Honor.

About Zahir Ibrahim

Ibrahim most recently served as Chief Financial Officer of BARK, Inc. (NYSE: BARK). Before BARK, he was Chief Financial Officer and Chief Administrative Officer of Do Good Foods. He previously served as Chief Financial Officer of KIND, where he helped build the infrastructure behind the healthy snack brand’s growth and international expansion and led the company through its sale to Mars in 2020. Before KIND, he was Chief Financial Officer of Annie’s, Inc., then listed on the NYSE, where he led the natural and organic food company through a period of significant growth and its sale to General Mills. Earlier, Ibrahim held several roles at Molson Coors Brewing Company, culminating as Vice President, Controller and Chief Accounting Officer. He trained as a Chartered Accountant with KPMG.

About Suja Life

At Suja Life, we’re changing what beverages bring to the table. We make organic, cold-pressed juices, wellness shots, and better-for-you sodas that deliver real functional benefits, exceptional taste, and high-quality ingredients, because we believe beverages should be as delicious as they are good for you. Our three brands – Suja Organic, Vive Organic, and Slice Soda – reach consumers through thousands of retail doors nationally. We operate a vertically integrated high-pressure processing and cold-pressed beverage facility, processing approximately 1 million pounds of organic produce each week and moving from farm to bottle in as few as eight days. With category-leading brands, a dedication to operational excellence, and a proven innovation engine, Suja Life is positioned at the front of the growing natural healthy beverage space.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. These statements may include words such as “anticipate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future performance or other events. For example, statements regarding Mr. Engel’s and Mr. Ibrahim’s expected contributions to the Company are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including: the ability of our newly appointed directors to contribute to the Board and its committees as anticipated; our ability to execute our growth strategy; and the other factors set forth in our filings with the U.S. Securities and Exchange Commission.

The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Investor and Press Contact

Michael Mougias
Investors@Sujalife.com
Press@Sujalife.com

BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) — Today, Flywire Corporation (Flywire) (Nasdaq: FLYW), a global payments enablement and software company, announced that its third quarter financial results will be released after market close on Tuesday, November 3, 2026. Flywire will host a conference call to discuss its third-quarter financial results at 5:00 pm ET the same day. Hosting the call will be Mike Massaro, CEO, Rob Orgel, President and COO, and Cosmin Pitigoi, CFO.

The conference call will be webcast live from Flywire’s investor relations website at https://ir.flywire.com/. A replay will be available on the investor relations website following the call.

About Flywire
Flywire is a global payments enablement and software company. We combine our proprietary global payments network, next-generation payments platform, and vertical-specific software to deliver the most complex and critical payments for our clients and their customers.

Flywire leverages its vertical-specific software and payments technology to deeply embed within the existing A/R workflows for its clients across the education, healthcare, and travel vertical markets, as well as in key B2B industries. Flywire also integrates with leading ERP systems, such as NetSuite, so organizations can optimize the payment experience for their customers while eliminating operational challenges.

Flywire supports over 5,300** clients with diverse payment methods in more than 140 currencies across over 240 countries and territories worldwide. The company is headquartered in Boston, MA, USA, with global offices. For more information, visit www.flywire.com. Follow Flywire on X, LinkedIn, and Facebook.

Contacts
Investor Relations:
Masha Kahn
ir@Flywire.com 

Media:
Sarah King
media@flywire.com

**Excludes clients from Flywire’s Invoiced and Sertifi acquisitions

  • Rocket Doctor selected as a Best in Class Finalist in the “Civic Health: Affordability, Access & Health Equity” category out of 1,800 global applicants.

  • Company featured in the “Innovations from Canada” Pavilion and pitch competition at HLTH in Las Vegas on November 16, 2026.

VANCOUVER, British Columbia, Oct. 20, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc.  (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) is pleased to announce that its wholly owned subsidiary, Rocket Doctor Inc., has been selected as a Finalist in the 8th Annual Digital Health & AI Awards, hosted by the Digital Health Hub Foundation at HLTH 2026 in Las Vegas.

Rocket Doctor was selected as one of only five finalists in the “Best in Class” Track for Civic Health: Affordability, Access & Health Equity, chosen from a competitive field of over 1,800 submissions worldwide. The recognition honors companies delivering remarkable innovation, measurable clinical impact, and transformation across the digital health and AI ecosystem.

In addition to being named an award finalist, Rocket Doctor will participate in the “Innovations from Canada” Global Village on Monday November 16th at HLTH, presenting a pitch in the showcase, and will be prominently featured in the “Innovations from Canada” Pavilion, highlighting top Canadian digital health companies supported by the MaRS and D3 Accelerators.

“Being recognized as a finalist from among 1,800 global digital health innovators is a huge honor, and a strong validation of our mission,” said Dr. William Cherniak, Founder & CEO of Rocket Doctor Inc. “Our AI-driven platform and physician marketplace were built specifically to address critical healthcare gaps, making high-quality care accessible, affordable, and equitable for remote, rural, and underserved populations across North America, particularly for individuals on Medicaid and Medicare across the United States. We look forward to sharing our vision and presenting on stage at HLTH in Las Vegas.”

The 8th Annual Digital Health & AI Awards Grand Finale will take place on November 16th, 2026, at HLTH in Las Vegas, bringing together leaders, investors, health systems, and innovators from across the global healthcare ecosystem.

About Rocket Doctor AI Inc.

Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs to provide care to more than 800,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices – improving efficiency, restoring autonomy to MDs, and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare – making it more scalable, equitable, and patient-centered.

To learn more about Rocket Doctor AI Inc’s products and services, contact: www.rocketdoctor.ai or email: info@rocketdoctor.ai

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO, Rocket Doctor AI essam.hamza@rocketdoctor.ai

Dr. Bill Cherniak, CEO, Rocket Doctor Inc.bill@rocketdoctor.io For media inquiries, contact: media@rocketdoctor.ai Call: +1 (778) 819 8321

Cautionary Statements

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects[1] ” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Company’s participation in the 2026 Digital Health & AI Awards at HLTH, the anticipated pitch in the “Innovations from Canada” Global Village, showcasing in the “Innovations from Canada” Pavilion, and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.’s expectations include the Company’s inability to participate in the “Innovations from Canada” Global Village or Pavilion as anticipated, changes to or cancellation of the Annual Digital Health & AI Awards, the Company’s inability to realize the anticipated business, reputational or financial benefits of its finalist recognition, and other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

SINGAPORE, Oct. 20, 2026 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group”, “GNS” or the “Company”), a leading AI-powered education group, today reported unaudited financial results of its operations for the third quarter ended September 30, 2026.

The Company reported third quarter operational revenue of $4.1 million, an 81% increase from $2.3 million in Q3 2025. Revenue also grew 39% quarter-on-quarter compared to $2.9 million in Q2 2026, driven by growth across the Company’s three business units: Genius School, Genius Academy and Genius Resorts.

Quarterly gross profit grew 108% to $2.7 million, up from $1.3 million in the prior year period. Quarterly net profit from operations reversed from $1.2 million net loss from operations in Q3 2025 to $235,000 net profit from operations in Q3 2026.

This marked the third consecutive quarter of net profit from operations, with a cumulative nine month revenue of $10.3 million and cumulative nine month net profit from operations of $6.7 million.

Third Quarter 2026 Operational Financial Highlights

  • Revenue: Operational revenue of $4.1 million in Q3 2026, up 81% from $2.3 million in Q3 2025, and up 39% sequentially from $2.9 million in Q2 2026, driven by growth across all three business units.
  • Gross Profit: Gross profit of $2.7 million, a 108% increase from $1.3 million in Q3 2025. Gross margin expanded to 66.1% from 57.3%, reflecting the continued shift to higher-margin education programmes. Sequentially, gross profit grew 84% from $1.5 million in Q2 2026, with gross margin expanding by 15.9 percentage points from 50.2%.
  • Net Profit from Operations: The three operating business units collectively achieved $390,000 in operating profit, with all three units profitable in the quarter. Legacy costs from discontinued operations were $155,000, resulting in net profit from operations of $235,000 in Q3 2026, a reversal from a net loss from operations of $1.2 million in Q3 2025.
  • EBITDA: EBITDA of $261,000 in Q3 2026, compared to negative EBITDA of $742,000 in Q3 2025.
  • Cumulative Nine-Month Revenue: Cumulative revenue for the nine months ended September 30, 2026 was $10.3 million, up 112% from $4.9 million in the comparable prior year period.
  • Cumulative Nine-Month Gross Profit: Gross profit for the nine months was $6.2 million, up 147% from $2.5 million in the comparable prior year period, with gross margin improving to 60.3% from 51.9%.
  • Cumulative Nine-Month Net Profit from Operations: Net profit from operations for the nine months was $6.7 million, an $8.9 million reversal from a net loss from operations of $2.3 million in the comparable prior year period.

Roger James Hamilton, Founder and CEO of Genius Group, commented “The third quarter brought significant progress on the Company’s strategic and financial fronts. We have built and proven a profitable Genius City model, designed to be an integrated AI Powered lifelong learning campus with profitable revenues from Genius School for children and young adults, profitable revenue from Genius Academy for reskilling adults and profitable revenue from Genius Resorts providing F&B, entertainment and accommodation.”

“Now that we have built a profitable $10 million scalable model over the last nine months, we are now commencing our plans to scale our Genius City model globally towards our target of 100 Genius Cities. There is a growing need for data centers to deliver education and reskilling training and benefits to their local communities. Our Genius City model delivers this, empowering the communities that power AI.

Our financial wins in the last quarter are underpinned by our legal wins. On August 31, the Second Circuit Court of Appeals vacated the injunction that had restrained the Company from issuing shares, raising capital and purchasing Bitcoin. On September 27, the Federal Court denied all motions to dismiss our RICO lawsuit. We are now free to pursue the $1.2 billion capital plan we announced in August to fund our dual AI and Bitcoin treasury strategy, and we have relaunched our Bitcoin treasury in early October. We look forward to continuing our growth, as the community solution for the AI revolution.

Quarterly Reporting as a foreign private issuer

Genius Group is not required to file quarterly financial reports with the U.S. Securities and Exchange Commission. However, as part of the Company’s commitment to transparency and enhanced shareholder communication, the Company is voluntarily providing unaudited third quarter operational results. These results reflect the performance of the Company’s three operating business units – Genius School, Genius Academy and Genius Resorts – and do not include central treasury gains or losses, or central income or costs related to financing, investing, legal proceedings or central management fees. Audited financial results for the full fiscal year 2025 are available in the Company’s Annual Report on Form 20-F.

Q3 2026 Business Highlights

  • Launch of Genius OS AI-Powered Product Suite: In July, the Company launched Genius OS, its full AI-agent product suite spanning Genius School, Genius Academy, Genius Resorts and Genius City, connecting to over 300 AI models and offered on free, $9 per month and $90 per month subscription tiers.
  • Five-Star Hotel Certification: In July, Vision Villa Resort in Bali was awarded a Five-Star Hotel rating under Indonesia’s Star Hotel Tourism Business Certification Scheme, strengthening the Company’s hospitality brand.
  • Share Loyalty Bonus Program (Second Round): The Company launched the second round of its Share Loyalty Bonus Program with a record date of July 31, 2026, offering $0.10 per qualifying share for shareholders who maintain their shares in book entry through January 30, 2027.
  • Launch of $14 Million Genius City Project: In August, the Company launched the first phase of its $14 million Genius City joint venture at Nuanu Creative City, Bali, comprising Genius Zone, Genius Cafe, Genius Missions and Genius School.
  • Balance Sheet Restructuring: In August, the Company announced the completion of its balance sheet restructuring, with book value increasing 57% year-on-year to $106.6 million and net asset value per share of $0.61.
  • $1.2 Billion Capital Plan: On August 27, the Company announced a five-year capital plan under its $1.2 billion shelf registration, targeting $800 million in AI treasury assets, $827 million in Bitcoin treasury assets, and $2 billion in total assets by the financial year ending 2031.
  • Vacatur of Preliminary Injunction: On August 31, the U.S. Court of Appeals for the Second Circuit vacated the preliminary injunction that had restrained the Company from issuing shares, raising capital and purchasing Bitcoin since March 2025. The matter has been remanded to the district court.
  • RICO Lawsuit Motions to Dismiss Denied: On September 27, the Federal Court ruled in favor of Genius Group, denying all motions to dismiss in the Company’s RICO lawsuit against third parties.
  • School Enrolment Growth: The Company opened the 2026/27 school year at its Nuanu campus with 235 students, approximately 65% year-on-year enrolment growth, with capacity across its Bali campuses expanded to approximately 1,000 students.
  • Genius Future Summit: The Company announced the Genius Future Summit to be held November 5–6, 2026, featuring futurists Dr. Michio Kaku, Peter Diamandis and a lineup of world class entrepreneurs and thought leaders.

Recent Developments (Post Quarter-End)

  • CEO Share Purchase: On October 1, CEO Roger Hamilton purchased 1,000,000 Company shares on the open market, expressing confidence in the Company’s outlook.
  • Bitcoin Treasury Recommenced: On October 6, the Company announced the recommencement of Bitcoin treasury purchases.
  • Launch of Genius High: On October 13, the Company launched Genius High as a scalable model for AI-powered Future Schools, integrated with the Student AI and Teacher AI platforms, as part of Genius OS.

About Genius Group

Genius Group (NYSE: GNS) is a global education group delivering AI powered, education and acceleration solutions for the future of work. Genius Group serves 6 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level. To learn more, please visit geniusgroup.ai

Forward-Looking Statements 

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as “may,” “will”, “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 20-F, as may be supplemented or amended by the Company’s Reports of a Foreign Private Issuer on Form 6-K. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

Non-IFRS Financial Measure

We have included Adjusted EBITDA because it is a key measure used by our management and board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short- and long-term operational plans. In particular, the exclusion of certain expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core business. We calculate Adjusted EBITDA as net profit / loss for the period plus income taxes and social contribution plus / minus finance revenue / expense result plus depreciation and amortization plus impairments plus revaluation adjustment of contingent liabilities plus share-based compensation expenses plus bad debt provision.

Contacts

For enquiries, contact investor@geniusgroup.ai

NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (“Gemini”) (NASDAQ: GEMI), a crypto and markets company, today announced it will release its third quarter 2026 financial results after market close on Thursday, November 12, 2026. Management will host a conference call on Friday, November 13, 2026, at 8:30 a.m. ET to discuss the results.

Call registration and webcast details will be posted to the Events page of Gemini’s Investor Relations website (https://investors.gemini.com/) ahead of the call. Gemini also plans to host the webcast on its X and YouTube channels. Following the call, a replay and transcript will be available on Gemini’s Investor Relations website.

Channels for Disclosure of Information
As a reminder, Gemini announces material information to the public through filings with the Securities and Exchange Commission (SEC), the Investor Relations page on its website (investors.gemini.com), the Gemini Blog (www.gemini.com/blog), press releases, public conference calls, public webcasts, Gemini’s X account (@gemini), and Gemini’s LinkedIn page. The information disclosed in the foregoing channels could be deemed to be material information and Gemini uses these channels for complying with its disclosure obligations under Regulation FD. As such, investors, the media, and others are encouraged to monitor the channels listed above and to review the information disclosed through such channels.

About Gemini
Gemini (NASDAQ: GEMI) is a crypto and markets company founded by Cameron and Tyler Winklevoss in 2014. Gemini offers a wide range of crypto and markets products and services for individuals and institutions. Gemini’s simple, reliable, and secure products are built to unlock the next era of financial, creative, and personal freedom.

Contact

Investors
Gemini Investor Relations
Email: investors@gemini.com

Press
Jacqueline Ortiz Ramsay
Email: press@gemini.com

Planned $16 million facility at the Atlas Complex advances Callan JMB’s pharmaceutical manufacturing strategy and strengthens its role in U.S. healthcare supply-chain preparedness

SPRING BRANCH, Texas, Oct. 20, 2026 (GLOBE NEWSWIRE) — Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a diversified preparedness, logistics, and critical-infrastructure company, today announced formal approval of blueprints for the planned $16 million intravenous (IV) bag manufacturing and distribution facility at the Atlas Complex in Marion, Alabama. Once in production, the facility is projected to generate $450 million in annual revenue, including $300 million from standard IV bags and $150 million from premixed drug IV bags.

The facility is planned within the Marion 9 Biomanufacturing Center at the Atlas Complex and demonstrates Callan JMB’s previously announced pharmaceutical manufacturing initiative with Alabama State University. The blueprint approval significantly advances the project and provides the design basis for completing a successful facility by combining automated production with quality-control and advanced distribution capabilities.

“The commercial objective is clear: build improved domestic manufacturing capacity for essential IV products and support it with the logistics, quality controls, and distribution capabilities needed to serve healthcare customers,” said Wayne Williams, Callan JMB’s Chief Executive Officer. “Approving the blueprints is a concrete step toward that objective. This project builds on our healthcare logistics and emergency-preparedness experience while supporting the strengthening of the United States (U.S.) domestic pharmaceutical production, enhancing U.S. supply chain resilience, and improving national security through medical preparedness.”

The facility is designed to incorporate automation and robotics to support manufacturing efficiency, consistent production processes, and quality assurance. Integrating production with distribution capabilities is expected to streamline coordination across manufacturing, storage, and delivery of essential healthcare products.

For Callan JMB, the project extends its role in healthcare supply chains by supporting domestic pharmaceutical manufacturing. The Company’s logistics, monitoring, regulatory-compliance, and operational capabilities are intended to help connect production at Atlas with the healthcare organizations and other customers that rely on these products.

The planned IV bag manufacturing capacity also supports Callan JMB’s broader emergency-preparedness strategy. A domestic source of IV products, supported by coordinated warehousing and distribution, helps strengthen supply continuity for healthcare providers during routine operations and periods of heightened demand or disruption.

Through its collaboration with Alabama State University, the initiative is also expected to support important workforce development and increase research partnership agreements that can help meet the technical and operational requirements of pharmaceutical manufacturing. The planned investment would expand advanced manufacturing activity in Marion and create new opportunities for skilled employment in Perry County and the surrounding region.

About Callan JMB Inc.

Callan JMB Inc. (NASDAQ: CJMB) is a diversified logistics, preparedness, and critical-infrastructure company supporting healthcare organizations, government agencies, and commercial partners. The Company provides fulfillment, warehousing, cold-chain logistics, monitoring, regulatory compliance, specialty packaging, and emergency-preparedness services designed to protect critical products, strengthen supply chains, and support continuity of operations. Through its businesses and strategic partnerships, Callan JMB is building a broader platform spanning healthcare and pharmaceutical logistics, domestic manufacturing, and critical electrical infrastructure. For more information, visit www.callanjmb.com.

Investor Contact

Valter Pinto, Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
212.896.1254

Media Contact

Arian Hopkins
ahopkins@callanjmb.com

About the Atlas Complex by Callan JMB

Atlas Complex by Callan JMB is a pharmaceutical, medical, and logistics campus located in Marion, Alabama. Designed to support U.S. pharmaceutical onshoring and strengthen domestic supply chains, the campus provides scalable infrastructure for pharmaceutical manufacturing, quality assurance and quality control (QA/QC), research collaboration, workforce development, cold chain logistics, and domestic distribution within a single integrated environment.

Atlas Complex Media Contact
Arian Hopkins
ahopkins@callanjmb.com

Forward-Looking Statement

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by, or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the Company’s actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Registration Statement Under the Securities Act of 1933 on Form S-1, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.

CONSHOHOCKEN, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its third-quarter 2026 financial results on Tuesday, November 3, 2026, prior to the open of the U.S. financial markets.

Following the announcement, Madrigal’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

The live webcast may be accessed at the Investor Relations section of the Madrigal Pharmaceuticals website. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.

The webcast will be available approximately two hours after the live webcast.

About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra was the first medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit www.madrigalpharma.com.

Investor Contact
Tina Ventura, IR@madrigalpharma.com

Media Contact
Christopher Frates, media@madrigalpharma.com

VANCOUVER, British Columbia, Oct. 20, 2026 (GLOBE NEWSWIRE) — Riverside Resources Inc. (“Riverside” or the “Company“) (TSX-V: RRI) (OTCQB: RVSDF) (FSE: 5YY0), is pleased to announce that its subsidiary, Ravena Resources Corp. (“Ravena“), together with RRM Exploraciones, S.A.P.I. DE C.V., has completed an option agreement with 1559239 B.C. Ltd., operating as Calu Resources Corp (“Calu“) for the Cecilia Project in Sonora, Mexico. Under the agreement, Calu can earn 100% interest in the project by completing the business terms outlined below with a total earn-in work expenditure of $6,650,000. Ravena, the subsidiary of Riverside, will manage the exploration work and receive a 10% operations fee. The work will include an updated NI 43-101 report, followed by a firm commitment exploration program of at least C$150,000 in the first 12 months. Calu has made the initial payment of C$50,000 to Ravena to begin the option commitment. Calu is a new private company that intends to become public through a three-way amalgamation with Pender Capital. That transaction is described in a separate news release issued by Calu and Pender Street Capital Corp.

“Riverside is pleased to progress another property in its portfolio where Riverside retains a 2% NSR royalty and its subsidiary, Ravena Resources, receives option payments and acts as the operator of the exploration program,” said John-Mark Staude, CEO of Riverside Resources. “As we build our royalty portfolio, we are focusing on properties where discovery can add value to those royalties, particularly properties held through Riverside and, going forward, those included in the planned 2027 spin-out of Ravena Resources Corp. With more than C$6,500,000 in exploration expenditures under the earn-in, this agreement allows Cecilia to advance at no cost to Riverside.”

Option and Earn-In Terms

Under the Option Agreement, Calu may acquire a 100% interest in the Cecilia Project by making aggregate cash and share payments of C$1,200,000 and funding aggregate exploration expenditures of C$6,650,000 over five years, as follows:

Due Date Payments Cumulative Exploration Expenditures
Effective date of Option Agreement $50,000 in cash Nil
First anniversary $150,000 in cash or Calu shares $150,000
Second anniversary $150,000 in cash or Calu shares $500,000
Third anniversary $150,000 in cash or Calu shares $2,000,000
Fourth anniversary $200,000 in cash or Calu shares $2,000,000
Fifth anniversary $500,000 in cash $2,000,000
Total: $1,200,000 $6,650,000

Unless otherwise indicated, all amounts in this news release are expressed in Canadian dollars.

The initial C$50,000 cash payment and at least C$150,000 in exploration expenditures during the first 12 months are firm commitments of Calu under the Option Agreement. All remaining payments and exploration expenditures are optional, but Calu must complete them to keep the option in good standing and to exercise it.

Where permitted under the option agreement, Calu may elect, with at least 10 business days’ notice, to make all or part of a cash payment in Calu shares. The number of shares issued will be based on the 10-trading-day volume-weighted average price of Calu shares on a recognized stock exchange, subject to applicable securities laws and stock exchange policies. Shares will be issued fully paid and free of encumbrances, other than statutory resale restrictions.

Ravena will act as operator of all exploration programs on the Cecilia Project during the option period and will be entitled to a management fee equal to 10% of eligible exploration expenditures.

The Cecilia Project is subject to an existing 2.0% net smelter returns royalty in favour of 1412597 B.C. Ltd., a subsidiary of Riverside Resources Inc. Upon exercise of the option, Calu will grant Ravena an additional 0.5% net smelter returns royalty. Calu will have the right to purchase the entire 0.5% royalty from Ravena for US$1,500,000 in cash at any time prior to January 1, 2035.

Cecilia Project

The Cecilia Project is located in northeastern Sonora, Mexico, approximately 40 kilometres southwest of Agua Prieta, near the Mexico-United States border, and 100km due east of the Cananea large copper mining complex. Operations of Couer Mining, First Majestic, Agnico Eagle, Grupo Mexico, Penoles, Hylander Silver are all active in the area around the Project. Riverside’s exploration work has included drilling at four key targets that warrant follow-up exploration. Six additional targets are permitted for drilling and could host a new discovery as well. If exploration is successful, Riverside will benefit through its royalty interests in addition to the option payments. The main concession block includes the Cecilia 1 titled claim and collectively covers > 60 km2 of titled ground plus an additional 16 km2 of application ground for a total property area of approximately 7,583 hectares (76 km2). Further information about the property has been provided previously and is available on the Riverside website.

Northern Miner Interview

John-Mark Staude, President and CEO of Riverside, and Julian Manco, Vice President of Exploration for Ravena Resources, discuss the planned Ravena spin-out with The Northern Miner in a sponsored video interview recorded at the Precious Metals Summit: https://www.northernminer.com/stock-markets-investing/sponsored-riverside-readies-mexico-spinout/1003895457/.

Corporate News – Options Grant

On September 4, 2026 the Company granted incentive stock options to purchase an aggregate of 1,650,000 common shares of the Company to certain directors, officers, employees and consultants of the Company, in accordance with the Company’s Stock Option Plan. The options are exercisable at a price of $0.41 per share for a period of five years, expiring September 4, 2031. Options granted to Director’s vest in three equal installments of 33% on the six-month, twelve month and eighteen-month anniversaries. Options granted to certain officers, employees and consultants vest in four equal installments of 25% of the common shares on the three-month, six-month, nine-month and twelve-month anniversaries. The grant is subject to the policies of the TSX Venture Exchange.

Qualified Person & QA/QC

The scientific and technical data contained in this news release pertaining to the Project was reviewed and approved by Julian Manco, P.Geo, a non-independent qualified person to Riverside Resources Inc., who is responsible for ensuring that the information provided in this news release is accurate and who acts as a “qualified person” under National Instrument 43-101 Standards of Disclosure for Mineral Projects.

About Riverside Resources Inc.

Riverside is a well-funded exploration company driven by value generation and discovery. The Company has a solid balance sheet with no debt and fewer than 95M shares outstanding with a strong portfolio of gold-silver and copper assets and royalties in North America. Riverside has extensive experience and knowledge operating in Mexico and Canada and leverages its large database to generate a portfolio of prospective mineral properties. Riverside has properties available for option, with information available on the Company’s website at www.rivres.com. 

ON BEHALF OF RIVERSIDE RESOURCES INC.

“John-Mark Staude”

Dr. John-Mark Staude, President & CEO

For additional information contact:

John-Mark Staude
President, CEO
Riverside Resources Inc.
info@rivres.com
Phone: (778) 327-6671
Fax: (778) 327-6675
Web: www.rivres.com
Eric Negraeff
Corporate Communications
Riverside Resources Inc.
Eric@rivres.com
Phone: (778) 327-6671
TF: (877) RIV-RES1
Web: www.rivres.com


Certain statements in this press release may be considered forward-looking information, including statements regarding the Option Agreement, the planned exploration program, and payments and exploration expenditures to be made by Calu. These statements can be identified by the use of forward-looking terminology (e.g., “expects”, “estimates”, “intends”, “anticipates”, “believes”, “plans”). Such information involves known and unknown risks, including the risk that Calu does not complete the payments and exploration expenditures required under the Option Agreement, the risk that Calu’s proposed amalgamation with Pender Capital is not completed as contemplated, or at all, the value of any Calu shares issued as payment, availability of funds, the results of financing and exploration activities, the interpretation of exploration results and other geological data, unanticipated costs and expenses, and other risks identified by Riverside in its public securities filings, that may cause actual events to differ materially from current expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Foldable bicycle pioneer replaces a 12-year-old custom trade system as it invests in its global network of retail partners

AUSTIN, Texas and LONDON, Oct. 20, 2026 (GLOBE NEWSWIRE) — Commerce.com (Nasdaq: CMRC), the open commerce ecosystem built to help merchants win as AI reshapes how customers discover and buy, today announced that Brompton, the British foldable bicycle manufacturer, has launched its new Brompton Partner Portal on BigCommerce B2B Edition.

The portal gives Brompton’s global network of independent retailers a modern ordering experience and runs on the same BigCommerce instance and product catalog that powers the company’s direct-to-consumer business.

Brompton first launched its composable direct-to-consumer site on BigCommerce in 2024. The new partner portal extends that foundation to the wholesale side of the business, which accounts for roughly 75% of Brompton’s total sales across over 1,000 retail partners worldwide.

“Our retail partners are central to Brompton’s success. The new Partner Portal gives them a modern, intuitive way to explore our product range, place orders and access the information they need to support our joint customers,” said Oliver Boardman, CTO at Brompton. “This investment is about making it easier for our partners to do business with Brompton and grow alongside us.”

Retiring a decade-old bespoke platform

Brompton’s previous wholesale system was created more than a decade ago and was designed around the company’s highly configurable bicycles. As Brompton’s range expanded to include electric, titanium and large-wheel bikes, the breadth of products, options and content available to partners grew significantly.

The new Partner Portal provides a richer product experience, with clearer imagery, improved product information and curated catalogues that make it easier for partners to understand and access the full Brompton range, while also providing a more scalable foundation for future growth. Over time, Brompton plans to increase the range of tools it provides in the system to support its partners’ businesses.

Four months to launch with an in-house, AI-accelerated team

Where Brompton’s original DTC project took about a year to reach its first market, the company’s internal project team built and launched the partner portal in four months, leveraging its BigCommerce platform knowledge from the B2C site.

“This wasn’t just a technology project. It was delivered through close collaboration between teams across Brompton, combining deep knowledge of our products, partners and processes with the technical expertise to bring it all together. AI tools helped accelerate delivery, but the real success came from having engaged people across the business working towards a shared goal,” said Boardman. “That collaboration, combined with the knowledge we’ve built on the BigCommerce platform, allowed us to launch significantly faster while continuing to build our internal capabilities.”

A market-by-market rollout

The Partner Portal is live in Germany and Austria, with the remaining European markets and the UK to follow this month. Additional localization work for the U.S., Japan, China and Singapore is underway, with the full rollout targeted for completion ahead of the spring.

“Historically we had different systems for different things,” said Boardman. “We want to bring it all together so there’s a single place partners can come to interact with the brand. If we make it as easy as possible for people to work with us, that helps them give our customers a great experience.”

“For years, manufacturers put their digital investment into direct-to-consumer while their dealers made do with ordering tools no shopper would tolerate,” said Lance Owide, vice president of B2B product management at Commerce. “That gap is common across manufacturing, but it’s closing fast. Brompton deserves credit for recognizing the need to serve consumers and partners from one platform, one catalog and one team.”

Brompton joins a growing group of cycling and outdoor brands on the BigCommerce platform. See more here: https://www.bigcommerce.com/case-study/?industries=sports-%26-outdoors

Learn more about how BigCommerce supports B2B businesses: https://www.bigcommerce.com/solutions/b2b-ecommerce-platform/

About Commerce
Commerce (Nasdaq: CMRC) empowers businesses to innovate, grow, and thrive by providing an open, AI-driven commerce ecosystem. As the parent company of BigCommerce, Feedonomics, and Makeswift, Commerce connects the tools and systems that power growth, enabling businesses to unlock the full potential of their data, deliver seamless and personalized experiences across every channel, and adapt swiftly to an ever-changing market. Trusted by leading businesses like Coldwater Creek, Cole Haan, Dell, Harvey Nichols, King Arthur Baking Co., Mizuno, Pacsun, Perry Ellis, Skechers, SportsShoes and Uplift Desk, Commerce delivers the storefront control, optimized data, and AI-ready tools businesses need to grow, serve diverse buyers, and operate with confidence in an increasingly intelligent, multi-surface world. For more information, visit www.commerce.com or follow us on X and LinkedIn.

BigCommerce®, the Commerce logo, and other brands are the trademarks or registered trademarks of Commerce.com Pty. Ltd. Third-party trademarks and service marks are the property of their respective owner.

Media Contact:
Brad Hem
pr@commerce.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.